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After being ingested by a female Anopheles mosquito during a
bloodmeal on an infected host, and before they can reach the
mosquito salivary glands to be transmitted to a new host, Plasmo-
dium parasites must establish an infection of the mosquito midgut
in the form of oocysts. To achieve this, they must first survive a
series of robust innate immune responses that take place prior to,
during, and immediately after ookinete traversal of the midgut
epithelium. Understanding how parasites may evade these re-
sponses could highlight new ways to block malaria transmission.
We show that an ookinete and sporozoite surface protein desig-
nated as PIMMS43 (Plasmodium Infection of the Mosquito Midgut
Screen 43) is required for parasite evasion of the Anopheles coluzzii
complement-like response. Disruption of PIMMS43 in the rodent
malaria parasite Plasmodium berghei triggers robust complement
activation and ookinete elimination upon mosquito midgut traversal.
Silencing components of the complement-like system through RNAi
largely restores ookinete-to-oocyst transition but oocysts remain
small in size and produce a very small number of sporozoites that
additionally are not infectious, indicating that PIMMS43 is also essen-
tial for sporogonic development in the oocyst. Antibodies that bind
PIMMS43 interfere with parasite immune evasion when ingested
with the infectious blood meal and significantly reduce the preva-
lence and intensity of infection. PIMMS43 genetic structure across
African Plasmodium falciparum populations indicates allelic adapta-
tion to sympatric vector populations. These data add to our under-
standing of mosquito–parasite interactions and identify PIMMS43 as a
target of malaria transmission blocking.
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Enhanced vector control significantly reduced malaria cases inrecent years and, together with effective medicines and better
health care, decreased the number of malaria-associated deaths.
However, the effectiveness of these measures is currently com-
promised due to widespread mosquito resistance to insecticides
used in bed-net impregnation and indoor residual spraying, while
mosquito biting and resting behaviors have also changed in re-
sponse to these measures. As a result, no significant progress in
reducing the global malaria burden is recorded in the past years.
Therefore, additional tools for malaria control are needed, the
development of which could be guided by a better understanding
of disease transmission through the vector.
Mosquito acquisition of Plasmodium parasites commences when
a female Anopheles mosquito ingests gametocyte-containing blood
from an infected person. In the mosquito midgut lumen, game-
tocytes mature and produce gametes. Fertilization of gametes
leads to zygotes that soon develop to ookinetes and traverse the
midgut epithelium. At the midgut basal subepithelial space,
ookinetes differentiate into replicative oocysts wherein hundreds
of sporozoites develop within a period of 1 to 2 wk. Upon release
into the hemocoel, sporozoites—transported by the hemolymph—
traverse the salivary glands and infect a new host upon a next
mosquito bite.
Inside the mosquito, parasites are attacked by an array of immune
responses (1, 2). Most parasite losses occur during the ookinete-to-
oocyst transition (3, 4). Ookinete traversal of the mosquito midgut
leads to activation of JNK (c-Jun N-terminal kinase) signaling, in-
ducing apoptosis of the invaded cells. This response involves various
effectors, including heme peroxidase 2 and NADPH oxidase 5 that
potentiate nitration of ookinetes that are henceforth marked for
elimination by reactions of the mosquito complement-like system
(5, 6). These reactions are triggered upon ookinete exit at the
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midgut subepithelial space encountering the hemolymph that
carries the complement-like system.
The hallmark of the mosquito complement-like system is the
C3-like factor, TEP1 (7, 8). A proteolytically processed form of
TEP1, TEP1cut, circulates in the hemolymph as a complex with
LRIM1 and APL1C (9, 10). Upon parasite recognition, TEP1cut
is released from the complex and attacks the ookinete, triggering
in situ assembly of a TEP1 convertase that locally processes
TEP1 molecules that bind to the ookinete causing lysis and, in
some cases, melanization (11). These reactions are regulated by
CLIP-domain serine proteases and their inactive homologs (11,
12). Ookinete clearance is assisted by actin-mediated cellular
responses of invaded epithelial cells (13).
The characterization of Plasmodium falciparum Pfs47 as a
player in parasite evasion of the mosquito complement-like re-
sponse has opened new avenues to dissect the mechanisms para-
sites employ to endure or indeed evade the mosquito immune
response. glycosyl-phosphatidylinositol (GPI)-anchored Pfs47 was
hypothesized to interfere with activation of JNK signaling and,
by doing so, aids ookinetes to escape nitration and subsequent
complement-mediated attack (14, 15). This parasite immune
evasion function is shared by the Pfs47 ortholog in the rodent
malaria parasite Plasmodium berghei (16), which was earlier
thought to be solely involved in fertilization (17).
Our transcriptomic profiling of field P. falciparum isolates
from Burkina Faso in the midgut of sympatric Anopheles coluzzii
(previously Anopheles gambiaeM form) and Anopheles arabiensis
mosquitoes and a laboratory P. berghei strain in the midgut of A.
coluzzii (18) identified hundreds of genes exhibiting conserved
and differential expression during gametocyte-to-oocyst develop-
ment. Several of them encoding putatively secreted or membrane-
associated proteins were made part of a screen to identify genes
that function during parasite infection of the mosquito midgut.
These genes were given a candidate gene number preceded by the
acronym PIMMS, for “Plasmodium Infection of the Mosquito
Midgut Screen.” We previously characterized PIMMS2 that en-
codes a subtilisin-like protein involved in midgut traversal (19).
Here, we report the characterization of P. falciparum and P. ber-
ghei PIMMS43 that encodes a membrane-bound protein found on
the surface of ookinetes and sporozoites. The gene was first reported
in P. berghei to be a target of the transcription factor AP2-O, has a
role in mosquito midgut invasion and oocyst development, and was
named POS8 (20). A later study by another group reported the gene
as being important for ookinete maturation, designating it as
PSOP25 (21). Here we demonstrate that PIMMS43 has no de-
tectable function in ookinete maturation or mosquito midgut
invasion but plays a key role in ookinete evasion of the mosquito
complement-like response. We show that disruption of PIMMS43
leads to robust complement activation and ookinete elimination
upon completion of midgut traversal and before their trans-
formation to oocysts. When the complement system is inactivated,
oocyst transformation is restored but sporogony cannot be com-
pleted, as the gene is also essential for sporozoite development.
Parallel analysis of thousands of African P. falciparum parasites
reveals clear genetic differentiation between populations sampled
from West or Central and East African countries, inferring
parasite adaptation to sympatric vector populations. We further
demonstrate that A. coluzzii ingestion of antibodies against P.
falciparum PIMMS43 leads to strong inhibition of oocyst devel-
opment. The discovery and characterization of PIMMS43 adds
to our understanding of parasite immune evasion and malaria
transmission through the vector.
Results and Discussion
Identification of PIMMS43. P. falciparum (PF3D7_0620000) and P.
berghei (PBANKA_1119200) PIMMS43 encode deduced proteins of
505 and 350 amino acids, respectively. N-terminal signal peptides
(amino acids 1 to 25 for PfPIMMS43 and 1 to 22 for PbPIMMS43)
and C-terminal transmembrane domains (amino acids 482 to 504
for PfPIMMS43 and 327 to 350 for PbPIMMS43) are predicted for
both proteins. The transmembrane domains are predicted by Pre-
dGPI to also contain signals for attachment of a GPI lipid anchor
with 99% probability.
PIMMS43 is conserved among species of the Plasmodium
genus. All orthologs are predicted to contain the N-terminal
signal peptide and C-terminal transmembrane domain, as well
as a conserved pair of cysteine residues adjacent to the C ter-
minus (SI Appendix, Fig. S1). PbPIMMS43 exhibits a 68% se-
quence identity with orthologs in other rodent parasites (i.e.,
Plasmodium yoelii and Plasmodium chabaudi) and 27% and 24%
with P. falciparum and Plasmodium vivax PIMMS43, respectively.
PfPIMMS43 and PvPIMMS43 contain a 60 to 180 nonconserved
amino acid insertion with no obvious sequence similarity be-
tween them, which are therefore likely to have occurred in-
dependently. Another shorter, nonconserved insertion toward
the C terminus of P. vivax and Plasmodium knowlesi PIMMS43
includes tandem repeats of Glycine-Serine-Glutamine-Alanine-
Serine (GSQAS).
PIMMS43 Transcripts Peak in Ookinetes and Sporozoites. DNA
microarray profiling of A. coluzzii and A. arabiensis midguts in-
fected with P. falciparum field isolates in Burkina Faso revealed
that PfPIMMS43 (referred to in figures as Pfc43) shows pro-
gressively increased transcription that peaks 24 h postmosquito
blood feeding (hpbf) (Fig. 1A). These data were corroborated by
laboratory P. falciparum NF54 infections of A. coluzzii using RT-
PCR (SI Appendix, Fig. S2A). Low levels of PfPIMMS43 tran-
scripts were also detected in in vitro-cultured gametocytes but
not in in vitro-cultured asexual blood stage (ABS) parasites, in-
dicating that PfPIMMS43 transcription begins in gametocytes
and peaks in zygotes and ookinetes. Transcripts were not de-
tected in oocysts 10 d postmosquito blood feeding (dpbf) but
reappeared in mosquito salivary glands, indicative of PfPIMMS43
reexpression in sporozoites. While we do not detect PfPIMMS43
transcripts at 10 dpbf, two published RNA sequencing experiments
have shown that PfPIMMS43 transcripts are detected at 7 (22) and 8
dpbf (23) in the midgut oocysts, suggesting that PfPIMMS43 tran-
scripts may be too low to be detected at 10 dpbf in our assays.
We examined whether the P. berghei PIMMS43 ortholog (re-
ferred to in figures as Pbc43) shows expression profile similar to
PfPIMMS43, using quantitative real-time RT-PCR (qRT-PCR)
(Fig. 1B) and RT-PCR (SI Appendix, Fig. S2B). In these assays,
we used the P. berghei line ANKA507m6cl1 that constitutively
expresses GFP (24), hereafter referred to as c507, as well as the
nongametocyte producing ANKA 2.33 (NGP) as a control in the
RT-PCR assay. The results revealed low levels of PbPIMMS43
transcripts in mixed blood stages (MBS) and purified c507 ga-
metocytes, which together with absence of transcripts from NGP
MBS indicated that PbPIMMS43 transcription begins in gametocytes,
similar to PfPIMMS43. Also similar to PfPIMMS43, PbPIMMS43
transcript levels were very high 24 hpbf, as well as in purified in
vitro-produced ookinetes, indicating high PbPIMMS43 tran-
scription in ookinetes. Lower transcript levels were detected 2
dpbf, presumably due to ookinetes retained in the blood bolus
and the midgut epithelium and low-level expression in young
oocysts. No PbPIMMS43 transcripts were detected in mature
oocysts 10 dpbf, but strong PbPIMMS43 reexpression was observed
in salivary gland sporozoites. Taken together, these data indicate
that P. falciparum and P. berghei PIMMS43 exhibit similar tran-
scription patterns starting in gametocytes, peaking in ookinetes,
pausing in oocysts, and restarting in salivary gland sporozoites.
To investigate PbPIMMS43 protein expression, we raised
rabbit polyclonal antibodies against a codon-optimized fragment
of the protein (amino acids 22 to 327) expressed in Escherichia
coli cells (α-Pbc43opt), and a native protein fragment (amino
acids 22 to 331) expressed in insect Spodoptera frugiperda Sf9
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cells (α-Pbc43Sf9). Both recombinant proteins lacked the pre-
dicted signal peptide and C-terminal transmembrane domain.
We also generated a genetically modified c507 P. berghei line,
designated Δc43, where 50% of the PbPIMMS43 coding region
was replaced with a modified Toxoplasma gondii pyrimethamine-
resistance expression cassette (TgDHFR) (SI Appendix, Fig.
S3A). Integration of the disruption cassette was confirmed by
PCR and pulse field gel electrophoresis (SI Appendix, Fig. S3 B
and C). RT-PCR assays confirmed that PbPIMMS43 transcripts
could no longer be detected in gametocytes, ookinetes, and spo-
rozoites of the Δc43 line that was henceforth used as a negative
control in protein-expression experiments (SI Appendix, Fig. S2B).
Western blot analysis was performed in total, triton-soluble
protein extracts prepared under reducing conditions from MBS,
purified gametocytes, and in vitro-cultured ookinetes of the c507
and Δc43 P. berghei lines (Fig. 1C). Two clear bands of ∼37 and 75
kDa were detected in ookinete extracts of the c507 line. The
former band matches the predicted molecular weight of
PbPIMMS43 monomer and the latter band could correspond to
PbPIMMS43 dimer, either a homodimer formed upon disulfide
bonding of the conserved pair of cysteine residues or a hetero-
dimer. Indeed, under strong reducing conditions, the 75 kDa was
resolved in a single 37-kDa band, whereas under nonreducing
conditions only the 75 kDa band could be detected (Fig. 1D). This
assay was combined with membrane-fractionation of total in vitro
ookinete extracts, which revealed that both bands were only ob-
served in the insoluble fraction and the fraction solubilized by
triton, but not in the soluble (triton nontreated) fraction. These
data indicate membrane association of PbPIMMS43, in accor-
dance with the prediction of a transmembrane domain and
a GPI anchor.
We also raised a rabbit polyclonal antibody against a codon-
optimized coding fragment of P. falciparum PIMMS43 (amino
acids 25 to 481) expressed in E. coli cells and lacking the pre-
dicted signal peptide and C-terminal transmembrane domain
(α-Pfc43opt). We examined the affinity and specificity of this
antibody by generating and using a P. berghei c507 transgenic
line (PbPfc43), where PbPIMMS43 was replaced by PfPIMMS43
(SI Appendix, Fig. S4A). PCR genotypic analysis confirmed
successful modification of the endogenous PbPIMMS43 geno-
mic locus (SI Appendix, Fig. S4B), and RT-PCR analysis con-
firmed that PfPIMMS43 is transcribed in in vitro-cultured P.
berghei ookinetes (SI Appendix, Fig. S4C). Western blot analysis
of total protein extracts prepared from purified in vitro-cultured
PbPfc43 ookinetes using the α-Pfc43opt antibody revealed a strong
band of ∼60 kDa, corresponding to the predicted molecular
weight of the deduced PfPIMMS43 protein (SI Appendix, Fig.
S4D). This band was absent from c507 and Δc43 protein extracts,
confirming the specificity of the α-Pfc43opt antibody. It is note-
worthy that, in contrast to what was observed with the PbPIMMS43
protein, the results did not show dimerization of the ectopically
expressed PfPIMMS43 protein when the analysis was done under
nonreducing conditions (SI Appendix, Fig. S4D). While this may
represent a true difference between the P. berghei and P. falci-
parum PIMMS43 proteins, we cannot rule out the possibility that
PfPIMMS43 dimerization requires, in addition to the conserved
cysteine residues, a P. falciparum-specific cofactor that is not
present in P. berghei and may be related to the nonconserved N-
terminal amino acid insertion in PfPIMMS43.
PIMMS43 Protein Is Localized on the Parasite Membrane. We used
the α-Pfc43opt antibody in indirect immunofluorescence assays to
investigate the subcellular localization of PfPIMMS43 in P. fal-
ciparum NF54 parasite stages. Antibodies against the female
gametocyte and ookinete surface protein Pfs25 and the sporo-
zoite surface protein PfCSP (Circumsporozoite protein) were used
as stage-specific controls. The results showed that PfPIMMS43
prominently localizes on the surface of female gametes or early-
stage zygotes found in the A. coluzzii blood bolus 1 hpbf, as well as
on the surface of ookinetes traversing the mosquito midgut epi-
thelia and sporozoites found in the mosquito salivary gland lumen
at 25 hpbf and 16 dpbf, respectively (Fig. 2A). There was no evi-
dence of α-Pfc43opt antibody staining of in vitro-cultured asexual
blood stage or gametocytes, suggesting that expression of PfPIMMS43
protein starts after fertilization. No signal was detected with the
α-Pfc43opt rabbit preimmune serum that was used as a negative
control.
Immunofluorescence assays of P. berghei c507 and control
Δc43 parasite stages using the α-Pbc43opt antibody revealed that,
similarly to its P. falciparum ortholog, PbPIMMS43 localizes on
the surface of A. coluzzii midgut-traversing ookinetes and salivary
Fig. 1. PIMMS43 transcription profiles and protein expression. (A) DNA
microarray transcriptional profiling of Pfc43 in A. coluzzii (Ac) and A. ara-
biensis (Aa) midguts. Bars show transcript abundance at indicated time
points relative to 1 hpbf and are average of three biological replicates. Error
bars show SEM. (B) Relative abundance of Pbc43 transcripts in blood stages,
in vitro ookinetes, and A. coluzzii mosquito stages, as determined by qRT-
PCR in the c507 line and normalized against the constitutive expressed GFP.
Each bar is the average of three biological replicates. Error bars show SEM.
(C) Western blot analysis under reducing conditions (3% [vol/vol] 2-mer-
capthoethanol) using the α-Pbc43opt antibody on whole-cell lysates of c507
parasites. Pbc43 protein bands are indicated with asterisks. Δc43 parasites
were used as a negative control. GFP was used as a loading control. (D)
Western blot analysis under reducing (Left; 5% [vol/vol] 2-mercapthoethanol)
and nonreducing (Right) conditions using the α-Pbc43opt antibody on frac-
tionated in vitro ookinetes. Pbc43 protein bands are indicated with asterisks.
Δc43 ookinetes were used as a negative control. P28 and GFP were used as
stage-specific and loading controls, respectively. Soluble (Sol), Triton soluble
(Tri Sol), and insoluble (Insol) fractions are shown. Abbreviations: Gc(−), non-
activated gametocytes; Gc(+), activated gametocytes; Ook, ookinetes.
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gland sporozoites (Fig. 2B). For the control Δc43 line, which as
reported below does not develop beyond the ookinete stage,
sporozoites were obtained from infections of LRIM1 knockdown
(KD) mosquitoes (see below). Like PfPIMMS43, despite the
presence of transcripts, no signal was detected in gametocytes.
Furthermore, no PbPIMMS43 signal was detected in early-stage
zygotes present in the blood bolus 1 hpbf, suggesting that trans-
lation starts later during ookinete development. In both species,
the protein was detectable on the surface of 2-d-old oocysts found
on the A. coluzzii midgut cell wall and reappeared in sporozoites
found in mature P. falciparum oocysts 11 dpbf and P. berghei
oocysts 15 dpbf (SI Appendix, Fig. S5).
PIMMS43 Deletion Mutants Fail to Reach Oocyst-Stage Infection. We
phenotypically characterized the P. berghei Δc43 line generated
as described above. Consistent with the PbPIMMS43 expression
data, Δc43 parasites exhibited normal development in mouse blood
stages (SI Appendix, Fig. S6). Both male gametocyte activation, as
measured by counting exflagellation centers (Fig. 3A), and
macrogametocyte-to-ookinete conversion rate, both in vitro and in
the A. coluzziimidgut lumen (Fig. 3B), were comparable to the c507
parental line, indicating that no developmental defects are accom-
panying the parasite gametocyte-to-ookinete developmental transi-
tion. However, no oocysts were detected in A. coluzzii midguts at 3,
5, 7, or 10 dpbf, indicating complete abolishment of oocyst forma-
tion (Fig. 3C and SI Appendix, Table S1). Thus, oocyst and salivary
gland sporozoites were never observed, and transmission to mice
following mosquito bite-back was abolished (SI Appendix, Table S2).
To validate the specificity of this phenotype, we reintroduced
PbPIMMS43 into the Δc43 locus by replacing the TgDHFR gene
cassette with the PbPIMMS43 coding sequence flanked by its 5′
and 3′ untranslated regions (UTRs) and followed by the human
DHFR gene cassette (SI Appendix, Fig. S7A). Successful in-
tegration was confirmed with PCR (SI Appendix, Fig. S7B).
Phenotypic characterization of the resulting Δc43::c43wt parasite
line in A. coluzzii infections showed that oocyst development was
fully restored (SI Appendix, Fig. S7C and Table S1).
These data were in disagreement with those reported previ-
ously, which showed that PSOP25 knockout (KO) parasites exhibit
reduced ookinete conversion rates and defective ookinete mat-
uration (21). To investigate this discrepancy, we generated a
new PIMMS43 KO (Δc43red) line in the 1804cl1 (c1804) P. ber-
ghei line that constitutively expresses mCHERRY (25), using the
same disruption vector (PbGEM-042760) as the one used by the
authors of the previous study, which leads to 74% removal of the
gene coding region (SI Appendix, Fig. S8 A and B). Phenotypic
analysis showed that Δc43red parasites show normal ookinete
conversion rates both in vitro and in A. coluzzii infections but
produced no oocysts (SI Appendix, Fig. S8C), a phenotype
identical to that of the Δc43 line. Similar results were obtained in
infections of Anopheles stephensi, the vector of choice in the
previous studies (SI Appendix, Fig. S8D). Interestingly, the number
of oocysts in A. stephensi infections was very small but not zero.
This is consistent with the findings by Kaneko et al. (20), as well as
with the general understanding that the A. stephensi Nijmegen
strain, which was genetically selected for high susceptibility to
parasite infections (26), has a less robust immune response than
Fig. 2. PIMMS43 protein localization. (A) Immunofluorescence assays of P. falciparum NF54 parasites found in mosquito blood bolus of at 1 hpbf (Left),
ookinetes traversing the mosquito midgut epithelium at 25 hpbf (Center), and salivary gland sporozoites at 16 dpbf (Right), stained with α-Pfc43opt (green)
and the female gamete/zygote/ookinete α-Pfs25 (red) or sporozoite α-PfCSP (purple) antibodies. DNA was stained with DAPI. Staining with preimmune serum
was used as a negative control. (B) Immunofluorescence assays of P. berghei 507 early sexual stages (activated gametocytes and/or early zygotes) in mosquito
blood bolus at 1 hpbf (Left), ookinetes traversing the mosquito midgut epithelium at 25 hpbf (Center), and salivary gland sporozoites at 21 dpbf (Right),
stained with α-Pbc43opt (green), female gamete/zygote/ookinete surface α-P28 (red) or sporozoite surface α-PbCSP (purple) antibodies. DNA was stained with
DAPI. Staining of the Δc43 parasite with α-Pbc43opt was used as a negative control. Note that Δc43 sporozoites were obtained from infections of LRIM1 kd
mosquitoes. Images are de-convoluted projection of confocal stacks. BF, bright field. (Scale bars, 5 μm.)
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A. coluzzii. Nonetheless, no sporozoites were detected in the A.
stephensi midgut 15 dpbf (SI Appendix, Fig. S8E).
Ookinetes Lacking PIMMS43 Are Killed by the Mosquito Complement-
like Response upon Midgut Traversal. We examined whether the
PIMMS43 KO phenotype was due to defective ookinete motility
and, hence, capacity to invade or traverse the mosquito midgut
epithelium. Ookinete motility assays showed that Δc43 ookinetes
moved on Matrigel with average speed that was not significantly
different from c507 ookinetes (Fig. 3D).
Next, a potential defect in midgut epithelium invasion and
traversal was assessed in infections of A. coluzzii where CTL4 (C-
type lectin 4) was silenced by RNA interference. CTL4 KD leads
to melanization of ookinetes at the midgut subepithelial space
upon epithelium traversal providing a powerful means to visualize
and enumerate ookinetes that successfully traverse the midgut
epithelium. The number of Δc43 melanized ookinetes was compa-
rable to that of the c507 line that was used as control (Fig. 3E and SI
Appendix, Table S3), indicating that Δc43 ookinetes successfully
traverse the midgut epithelium but fail to transform to oocysts.
A similar phenotype was previously reported for P47 KO
parasites that are eliminated by mosquito complement-like re-
sponses upon emergence at the midgut subepithelial space (16).
To examine whether the same applies to Δc43 parasites, we in-
fected A. coluzzii mosquitoes in which genes encoding two major
components of the complement-like system, TEP1 and LRIM1,
were individually silenced. Enumeration of oocysts 10 dpbf, and
comparison with control mosquitoes injected with LacZ double-
stranded RNA, revealed that Δc43 oocyst development was
largely restored in both TEP1 and LRIM1 KD mosquitoes (Fig.
3F); although the numbers of recovered Δc43 oocysts were still
Fig. 3. Phenotypic analysis of P. berghei Δc43 KO mutant parasites. Male gametocyte activation measured as percentage of exflagellating male gametocytes
(A) and female gamete conversion to ookinetes in vitro (Left), and in vivo in the A. coluzziimidgut of (Right) (B) of c507 wt and Δc43 parasites. Error bars show
SEM. (C) Δc43 oocyst development at 3, 5, 7, and 10 dpbf in A. coluzzii. ***P < 0.0001, Mann–Whitney U test. (D) Speed of c507 wt and Δc43 ookinetes
measured from time-lapse microscopy, captured at one frame/5 s for 10 min. Red lines indicate mean and error bars show SEM. ns, not significant. (E) Melanized
ookinete numbers in CTL4 kd A. coluzzii infected with c507 wt and Δc43 parasite lines. Red lines indicate median; ns, not significant; n, number of biological
replicates. (F) Effect of LRIM1 and TEP1 silencing on Δc43 oocyst numbers in A. coluzzii midguts. dsLacZ-injected mosquitoes were used as controls. Red lines
indicate median; n, number of independent experiments; ***P < 0.0001, Mann–Whitney U test. (G) Representative images of rescued Δc43 oocysts in LRIM1 KD
mosquitoes showing variable morphology and smaller size compared to c507 wt oocysts. (Scale bars, 30 μm.) (H) Box plot of diameter measurements of Δc43 and
c507 wt oocysts at 14 and 16 dpbf. Upper and lower whiskers represent the largest and smallest oocyst diameter, respectively. Horizontal line in each box indicates
mean of 2 biological replicates and whiskers show SEM. N is number of oocysts; *P < 0.05, and ***P < 0.0001 using unpaired Student’s t test.
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lower than the numbers of WT (c507) oocysts in TEP1 and
LRIM1 KD mosquitoes (SI Appendix, Table S4).
Taken together, these data indicate that the absence of
PIMMS43 does not affect the capacity of ookinetes to invade and
traverse the mosquito midgut epithelium but instead required for
protection from or evasion of the mosquito immune response. The
observation that Δc43 oocyst numbers are still inferior to WT
parasite oocyst numbers in both TEP1 and LRIM1 KDmosquitoes
could suggest that immune responses additional to TEP1-mediated
killing of Δc43 ookinetes. Indeed, it has been previously shown that
some dead ookinetes in the midgut epithelium are not bound by
TEP1 (7), indicating alternative means employed by the mos-
quito to kill Plasmodium ookinetes. Other mosquito immune
factors, such as fibrinogen-related proteins (FREPs or FBNs)
and LRRD7, are also important for midgut infection (27, 28). Of
these, FBN9 is shown to colocalize with ookinetes in the midgut
epithelium, probably mediating their death (28). Any such
mechanism employed by the mosquito to kill Δc43 ookinetes
would have to be TEP1-independent. Since TEP1 attack is po-
tentiated by prior marking of ookinetes by effector reactions of
the JNK pathway (5, 6), it is plausible that Δpbc43 ookinetes are
excessively marked for death either by the same mechanism
observed for Pfs47-null mutants or an independent mechanism.
Alternatively, due to the spatial and temporal limitations of RNAi,
it is possible that residual activity of TEP1 and LRIMI retained in
the KD mosquitoes is responsible for the incomplete rescue of
Δc43 oocyst numbers. Nonetheless, all of the above scenarios
suggest that PIMMS43, like P47, directly or indirectly interferes
with the mosquito immune response promoting ookinete survival.
PIMMS43 Is Additionally Required for Oocyst Maturation and
Sporozoite Development. We observed that the rescued Δc43
oocysts in LRIM1 or TEP1 KD mosquitoes were morphologi-
cally variable and smaller in size compared to c507 oocysts (Fig.
3G). At 14 and 16 dpbf the average Δc43 oocyst diameter was
20.1 and 17.2 μm, compared to 27.4 and 30.9 μm of c507 oo-
cysts, respectively (Fig. 3H). All pairwise comparisons were
statistically significant and revealed that the mean Δc43 oocyst
diameter at 16 dpbf was smaller than 14 dpbf, indicating pro-
gressive degeneration of Δc43 oocysts. In addition, Δc43 oocysts
in LRIM1 KD mosquitoes yielded a very small number of
midgut and salivary gland sporozoites compared to c507 oo-
cysts, and the ratio of salivary gland to midgut sporozoites was
significantly smaller for Δc43 compared to control c507 parasites
(SI Appendix, Table S6). Furthermore, the few Δc43 sporozoites
that reached the salivary glands of in LRIM1 KD mosquitoes
could not be transmitted to mice through mosquito bites.
These data suggested that Δc43 parasites are defective not only
with respect to ookinete toleration of the mosquito complement-
like response but also with sporozoite development and infectivity.
We investigated whether bypassing midgut invasion, a process in
which ookinetes are marked for elimination by complement-like
reactions, could rescue Δc43 sporozoite development and trans-
mission to a new host. In vitro-produced Δc43 and control c507
ookinetes were injected into the hemocoel of A. coluzzii mosqui-
toes, and sporozoites found in the mosquito salivary glands 21
d later were enumerated. The results revealed that no Δc43 spo-
rozoites could be detected in the mosquito salivary glands, and
consequently, mosquitoes inoculated with Δc43 ookinetes could
not transmit malaria to mice, in contrast to mosquitoes inoculated
with c507 ookinetes (SI Appendix, Table S6). While these data
argue for an additional, essential function of PbPIMMS43 in
sporozoite development, complement-independent effects directly
impacting the injected ookinete may be responsible for the spo-
rozoite phenotype observed in this experiment.
Next, we investigated whether PfPIMMS43 could complement
the function of its P. berghei ortholog by infecting naïve A.
coluzzii mosquitoes with the PbPfc43 parasite line and counting
the number of oocysts detected in the mosquito midguts. Infec-
tions with c507 and Δc43 parasites served as positive and negative
controls, respectively. The results showed that the PbPfc43 line
exhibited an intermediate phenotype compared to c507 and Δc43
both in terms of both infection prevalence and intensity (SI Ap-
pendix, Fig. S4E and Table S4). Oocysts were morphologically
variable and smaller in size compared to c507 oocysts and con-
tained a small number of sporozoites that could not be transmitted
to a new mouse host (SI Appendix, Table S5), resembling the
phenotype obtained with Δc43 infections following silencing of the
mosquito complement-like system. We examined whether this
partial complementation phenotype could be affected upon
LRIM1 silencing. Indeed, a significant increase in both the in-
fection prevalence and oocyst numbers was observed (SI Appendix,
Fig. S4E and Table S4), yet oocysts remained small and mor-
phologically variable and produced few sporozoites (SI Appendix,
Table S5). These results suggest that PfPIMMS43 can only partly
complement the function of its PbPIMMS43 ortholog and cor-
roborate the dual function of PIMMS43 in ookinete to oocyst
transition and in oocyst maturation and sporozoite development,
respectively.
PIMMS43 KO Leads to Compromised Ookinete Fitness and Attack by
the Complement-Like Response. We carried out RNA next-
generation sequencing of P. berghei Δc43 and c507 infected A.
coluzzii midguts at 1 and 24 hpbf to further investigate the Δc43
phenotype during mosquito midgut infection. P. berghei and A.
coluzzii transcriptomes were processed separately, and compar-
atively analyzed at each time point for each parasite line
(Datasets S1 and S2). Three independent biological replicates
and three technical replicates for each biological replicate were
performed.
At 1 hpbf, when asexual parasite stages and gametocytes are
sampled from the mosquito blood bolus, almost all 17 changes
registered between Δc43 and c507 parasites concerned genes
belonging to multigene families (pir, fam-a, and fam-b) and ri-
bosomal RNAs (SI Appendix, Fig. S9A). We hypothesize that this
is due to differential expression of such genes between clonal
parasite lines rather than differences related to the disruption of
PbPIMMS43. As many as 163 genes were differentially regulated
between the Δc43 and c507 parasites at 24 hpbf, of which 137
were down-regulated (41 at least twofold) and 26 were up-
regulated (9 at least twofold) (Fig. 4A). Gene ontology analysis
revealed several biological processes and three cellular compo-
nent terms that were significantly enriched in the differentially
regulated gene set (SI Appendix, Table S7). All gene ontology
terms were related to host–parasite interactions, including
micronemal secretion, entry into host cell, and parasite move-
ment. Genes included in this list encode known ookinete se-
creted or membrane-associated proteins—such as CTRP, SOAP,
MAEBL, WARP, PLP3-5, PIMMS2, HADO, PSOP1, PSOP7,
PSOP26, GAMA (also known as PSOP9)—and others, all of
which were down-regulated in Δc43 parasites. The expression of
the oocyst capsule protein Cap380 gene that begins in ookinetes
was also affected (29).
These data could be explained by a smaller ratio of ookinetes
to other parasite stages sampled from the midgut at 24 hpbf in
Δc43 infections compared to c507 infections. Although the data
from the ookinete melanization assays showed that differences
between Δc43 and c507 in ookinete numbers exiting the mos-
quito midgut were not statistically significant (P = 0.0947), these
differences were almost twofold both with regards to median and
arithmetic mean (SI Appendix, Table S3). This difference could
justify the observed twofold down-regulation of genes showing
enriched expression in ookinetes. A second hypothesis is that Δc43
parasites exhibit deficient expression of genes involved in ookinete
secretions and movement. The latter hypothesis is less appealing,
as it is difficult to explain how absence of a membrane-associated
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protein without obvious signaling domains could affect the tran-
scription of all other genes. However, the two hypotheses are not
mutually exclusive, and both indicate that disruption of PIMMS43
leads to compromised ookinete fitness.
Analysis of A. coluzzii midgut transcriptional responses to in-
fection by Δc43 compared to c507 identified 192 and 122 differ-
entially regulated genes at 1 and 24 hpbf, respectively (Dataset
S2). At 1 hpbf, 154 (88 over twofold) genes were down-regulated
and 38 (21 over twofold) were up-regulated (SI Appendix, Fig.
S9B). However, these genes did not appear to follow any func-
tional pattern, and annotation enrichment analyses did not yield
any significant results. In contrast, at 24 hpbf, and although the
number of identified genes was smaller (109 down-regulated, 71
over twofold; 13 up-regulated, 5 over twofold), most genes shown
to date to be involved in systemic immune responses of the
complement-like system and downstream effector reactions—in-
cluding TEP1, LRIM1, APL1C, and various clip-domain serine
protease homologs—were down-regulated (Fig. 4B). Enrichment
analysis confirmed that the serine protease/protease/hydrolase and
the serine protease inhibitor/protease inhibitor protein classes
were significantly overrepresented in this gene list. When considered
together with the increased complement activity observed
against Δc43 compared to the c507 ookinetes, these data could
suggest induction of a negative feedback mechanism to down-
regulate this self-damaging innate immune response. However,
most of these genes are thought to be largely, and in some cases
exclusively, expressed in hemocytes and fat body cells; therefore,
their detection as down-regulated in midgut tissues cannot be easily
explained. Thus, a more possible explanation is that midgut in-
fection by Δc43 ookinetes causes mobilization and differentiation of
hemocytes attached to the midgut tissues, as shown previously (30–
32), causing a temporal depletion of relevant transcripts from the
midgut tissue.
We examined this hypothesis by measuring the abundance of
transcripts encoding the three major components of the complement-
like system, TEP1, LRIM1, and APL1C, in the midgut and whole
body (excluding legs, wings, and heads) of A. coluzzii mosquitoes
infected with Δc43 or control c507 parasites at 24 hpbf. Since the
Δc43 phenotype was similar to the Δpbp47 phenotype (16), and
because preliminary data indicated similar A. coluzzii midgut
responses to the two mutant parasite lines, transcript abundance
in infections with Δpbp47 parasites were also examined. The
results revealed a striking difference in transcript abundance of
all three genes between midgut and whole mosquitoes (SI Ap-
pendix, Fig. S10). In accordance with the RNA-sequencing data,
the relative transcript abundance in infections with the two
mutant parasite lines compared to control infections was lower in
the midgut but higher in whole mosquitoes. These data are
consistent with our hypothesis that ookinetes lacking PIMMS43
or P47 trigger hemocyte mobilization and consequent depletion
in the midgut tissue, although the up-regulation of the three
genes in whole mosquitoes could also be explained by up-
regulation in other immune tissues, such as the fat body.
PIMMS43 Exhibits Significant Geographic Structure Among African P.
falciparum Populations. It has been shown that Pfs47 presents
strong geographic structure in natural P. falciparum populations,
both between continents and across Africa (33–35). Further-
more, a small-scale genotypic analysis of oocysts sampled from
A. gambiae and Anopheles funestus mosquitoes in Tanzania
revealed significant differentiation in Pfs47 haplotypes sampled
from the two vectors (36). These data are consistent with natural
selection of Pfs47 haplotypes by the mosquito immune system
and a key role of this interaction in parasite–mosquito co-
evolution (34). However, a different study showed that poly-
morphisms in the Pfs47 locus alone could not fully explain the
observed variation in complement-mediated immune evasion of
African P. falciparum strains (37).
We investigated the genetic structure of African P. falciparum
populations with regards to PfPIMMS43, and compared this to
the structure of Pfs47, using a rich dataset of 1,509 genome se-
quences of parasites sampled from 11 African countries in the
context of the P. falciparum Community Project (http://www.
malariagen.net/). The PfPIMMS43 analysis revealed significant
population differentiation as determined by the Fixation Index
(FST), mostly between populations of some West or Central
(Democratic Republic of the Congo, DC) and East African
countries (FST > 0.1) (Fig. 5). The highest FST is detected in
comparisons of Ugandan, DC, or Kenyan populations with West
African populations. The most differentiated single nucleotide
polymorphisms (SNPs) are detected within the nonconserved
region that is unique to P. falciparum (Dataset S3). Within this
region, an SNP that leads to the nonsynonymous substitution of
Serine-217 to Leucine (S217L) is highly differentiated between
sampled Kenyan/Tanzanian and all other populations, while a
nearby SNP that leads to substitution of Glutamate-226 to Lysine
(E225K) has swept to almost fixation in Ugandan populations.
The PIMMS43 FST profile does not fully match the FST profile
of Pfs47 that also presents strong genetic differentiation between
Fig. 4. P. berghei and A. coluzzii gene expression 24 hpbf. (A) Volcano plot
of P. berghei gene expression in Δc43 vs. c507 wt parasite lines in the A.
coluzzii midgut. (B) Volcano plots of A. coluzzii midgut transcriptional re-
sponses to Δc43 vs. c507 wt parasites. The x axes show log2 fold-change and y
axes show log10 P value calculated using one-way ANOVA. Blue and orange
filled circles indicate genes that are at least twofold down down-regulated
and twofold up-regulated, respectively. Black circles show with no signifi-
cant differential regulation. Known gene names are indicated.
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West and East Africa but is particularly strong for populations
sampled in Madagascar and Malawi versus West African and DC
populations (SI Appendix, Fig. S11). The most highly differenti-
ated SNPs are within domain 2 (D2) of the protein (Dataset S3).
An SNP leading to substitution of Leucine-240 to Isoleucine
(L240I) is almost fixed in Madagascar and Ugandan versus West
African populations, while a nearby SNP leading to the non-
synonymous substitution of Asparagine-271 to Isoleucine (N271I)
is highly prevalent in DC versus all other populations, especially
those sampled from East Africa. Our analysis also detected all
four SNPs previously shown to differentiate between African
(NF54) and New World (GB8) P. falciparum laboratory lines and
lead to amino acid substitutions in the D2 region that contribute
to immune evasion (38); however, these SNPs were neither highly
prevalent nor did they present significant geographic structure
apart from that leading to Isoleucine-248 substitution to Leucine
or Valine (I258L/V) that is significantly prevalent (FST > 0.1) in
sampled Ugandan populations. These data concur with the hy-
pothesis presented previously that polymorphisms in the D2 region
of Pfs47, even those leading to synonymous substitutions, can alter
the parasite immune evasion properties (38). Finally, one of the
substitutions defining the East versus West African differentiation is
that of Glutamate-27 to Aspartate (E27D) at the start of the
mature protein. This SNP is almost fixed in sampled Madagascar
populations.
Together, these data reveal that PfPIMMS43 and Pfs47 exhibit
significant geographic structure, consistent with their deduced
role in parasite immune evasion. They also suggest that different
selection pressures are exerted on each of these genes, which
concurs with the hypothesis that the two proteins serve different
functions. A major difference between West and East African
vector species is the presence of both A. gambiae (A. gambiae S-
form) and A. coluzzii (A. gambiae M-form) in West Africa but
only A. gambiae in East Africa. Interestingly, a resistant allele of
TEP1, TEP1rB, is shown to have swept to almost fixation in West
African A. coluzzii but be absent from A. coluzzii sampled from
Cameroon, consistent with the high PfPIMMS43 FST observed
between Central and West African parasite populations, as well
as from all sampled A. gambiae populations (39). Therefore, it is
tempting to speculate that a difference between West and East
African vectors in their capacity to clear parasite infections
through complement responses may have contributed to the
observed PfPIMMS43 and Pfs47 genetic structure.
Moreover, A. funestus and A. arabiensis appear to have re-
cently taken over from A. gambiae as the primary malaria vectors in
many areas of East Africa (40), in contrast to West Africa where A.
gambiae and A. coluzzii remain the primary vectors. While nothing is
known about the capacity of A. funestus to mount complement-like
responses against malaria parasites, A. arabiensis is shown to be a
less good vector of P. berghei but can be transformed into a
highly susceptible vector, equal to A. gambiae, when its com-
plement system is silenced (41). Finally, Anopheles merus is only
found in coastal East Africa; although its abundance and con-
tribution to malaria transmission has been increasing (42) it is
unlikely that it has majorly contributed to structuring parasite
populations.
Incubation with Anti-PIMMS43 Antibodies Significantly Reduces
Malaria Transmission by A. coluzzii. We examined in both P. falci-
parum and P. berghei whether targeting PIMMS43 using anti-
bodies generated against each of the respective orthologous
proteins could reduce parasite infectivity and malaria transmission
potential. For P. falciparum transmission-blocking assays, purified
IgG α-Pfc43opt antibodies were added to gametocytemic blood at
final concentrations of 0, 50, 125, and 250 μg/mL prior to offering
this as bloodmeal to female A. coluzzii mosquitoes through opti-
mized standard membrane feeding assays (SMFAs) (43). Oocysts
present in mosquito midguts at day 7 postfeeding were enumer-
ated. The results showed strong inhibition of both infection intensity
and infection prevalence in an antibody dose-dependent manner
(Fig. 6A and SI Appendix, Table S8). At 125 and 250 μg/mL of
antibody following four biological replicates, the overall inhibition
of infection intensity observed was 57.1% and 76.2%, and the
overall inhibition of infection prevalence was 37.3% and 35.6%,
respectively (P < 0.0001).
Similar results were obtained with P. berghei transmission upon
addition of α-Pbc43Sf9 antibodies to blood drawn from infected
mice and provided to mosquitoes as bloodmeal in SMFAs. Sta-
tistically significant inhibition of both infection intensity and
prevalence was detected at all antibody concentrations tested (i.e.,
50, 100, and 250 μg/mL) in an antibody dose-dependent manner
(Fig. 6B and SI Appendix, Table S9). At 100 μg/mL, the inhibition
of oocyst intensity was 72.7% and the inhibition of infection
prevalence was 35.5%, and these values increased to 90.3% and
65.6% at 250 μg/mL, respectively (P < 0.0001).
A recent study has shown that antibodies binding a 52-amino
acid region of Pfs47 confer strong transmission blocking of lab-
oratory P. falciparum strains in A. gambiae (44). In the same
study, antibodies binding different regions of the protein showed
either weak or no transmission-blocking activity, consistent with
an earlier study reporting that none of three monoclonal anti-
bodies against Pfs47 could affect P. falciparum infections in A.
stephensi (45). These findings agree with the general un-
derstanding that antibodies binding different regions of a tar-
geted protein can have profound differences in their blocking
activity, especially when antibodies have a primarily neutralizing
function (46, 47). Indeed, our polyclonal α-Pbc43opt antibody
raised against codon-optimized PbPIMMS43 expressed in E. coli
Fig. 5. Population genetic analysis of PfPIMMS43 in African P. falciparum.
PfPIMMS43 FST values of 1,509 P. falciparum populations sampled from pa-
tients across Africa (Upper) and schematic representation of SNPs with high
FST values leading to amino acid substitutions in each deduced protein
(Lower). (Upper) Color coding indicates comparisons between countries in
West, Central, and East Africa. Central Africa includes populations sampled
only from the DC. White bars overlaid with colored bars indicate the FST of
Pfs47. (Lower) Boldfaced amino acid substitutions are those deriving from
SNPs with total FST > 0.1, and the rest of the substitutions are those showing
high FST in comparison between populations sampled from specific coun-
tries. Substitutions marked with red stars are those showing very high FST
and have swept to almost fixation in some populations. Yellow spikes show
the positions of conserved cysteine residues. Burkina Faso, BF; Democratic
Republic of the Congo, DC; Gambia, GM; Ghana, GH; Guinea, GN; Kenya, KE;
Madagascar, MG; Malawi, MW; Mali, ML; Tanzania, TZ; Uganda, UG.
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cells appeared to not exhibit any transmission-blocking activity
against P. berghei, despite producing strong signals in Western blot
analyses and immunofluorescence assays. However, antibodies
against fragments of PSOP25 (synonym of PIMMS43) expressed in
E. coli cells have been previously shown to inhibit P. berghei in-
fection in A. stephensi (21, 48), albeit not as strongly as our
α-Pbc43Sf9 antibodies.
Concluding Remarks and Perspectives.We demonstrate that PIMMS43
is required for parasite evasion of the mosquito immune response, a
role also shared by P47 in both P. falciparum and P. berghei (14,
16). The mechanism by which these molecules exert their
function is unclear. A general explanation may lie with their
GPI constituents or with their structural role in the formation
of the ookinete sheath. On the one hand, Plasmodium GPIs are
known to modulate the vertebrate host immune system (49),
and studies have shown that mosquitoes mount a specific im-
mune response against GPIs (50, 51). On the other hand, the
integrity of the ookinete sheath may be important for coun-
teracting attacks by or acting as molecular sinks of free radicals
produced during traversal of midgut epithelial cells (5, 6) or by
directly enduring the attack of the complement-like system.
Ookinetes lacking such membrane proteins may thus be irreversibly
damaged and subsequently eliminated by the mosquito complement-
like response. In relation to this, a specific function could be
attributed to the conserved cysteine residues present in these
proteins. Apart from their role in forming disulphide bridges,
thus serving a structural purpose, the ability of cysteine thiol
groups to regulate the redox potential may be relevant (52).
Interestingly, midgut infection with P. berghei is shown to inhibit
the expression of catalase that mediates the removal of free rad-
icals, and silencing catalase exacerbates ookinete elimination (53).
Nonetheless, population genetic analyses indicate a more specific
role of the two proteins in parasite–mosquito interactions and
coadaptation.
Notwithstanding their exact function in parasite immune
evasion, PIMMS43, P47, and possibly other proteins involved in
parasite immune evasion are targets of interventions aiming to
block malaria transmission in the mosquito. One such approach
is transmission-blocking vaccines aiming at generating antibodies
in the human serum which, when ingested by mosquitoes to-
gether with gametocytes, interfere with the function of these
proteins and block transmission to a new host (54). Several pu-
tative transmission-blocking vaccines are currently being in-
vestigated at a preclinical stage, including those targeting the
gametocyte and ookinete proteins Pfs230, Pfs48/45, and Pfs25
(55). Another, more ambitious approach is the generation of
genetically modified mosquitoes expressing single-chain anti-
bodies or nanobodies that bind these proteins conferring re-
fractoriness to infection and leading to malaria transmission
blocking (56, 57). Such genetic features can be spread within wild
mosquito populations in a super-Mendelian fashion via means of
gene drive (e.g., CRISPR/Cas9) and can lead to sustainable local
malaria elimination (58).
Fig. 6. P. falciparum and P. berghei transmission blocking with anti-
PIMMS43 antibodies. Transmission-blocking efficacies of anti-PIMMS43 an-
tibodies on (A) P. falciparum and (B) P. berghei infections of A. coluzzii
shown as dot plots of oocyst number distribution (Upper) and forest plots of
generalized linear mixed-model analysis (Lower). The α-Pfc43opt and
α-Pbc43Sf9 antibodies were provided through SMFAs at concentrations of 50,
125, and 250 μg/mL, and 50, 100, and 250 μg/mL, respectively, and compared
with no antibodies and UPC10 antibodies that were used as negative con-
trols for P. falciparum and P. berghei, respectively. Individual data points
represent oocyst numbers from individual mosquitoes at 7 and 10 dpbf from
two/four and three biological SMFA replicates with P. falciparum and P.
berghei, respectively. m/M are mean/median oocyst infection intensities, also
shown as horizontal blue and red lines, respectively. IP, oocyst infection
prevalence; N, number of midguts analyzed; n, number of independent
experiments; ns, not significant. Statistical analysis was performed with
Mann–Whitney U test for infection intensity and Fisher’s exact test for in-
fection prevalence; **P < 0.005; ***P < 0.0001. In generalized linear mixed-
model analyses, the variation of fixed-effect estimates for each replicate
(squares) and all replicates (diamonds) are shown (±95% confidence interval,
glmmADMB). The square size is proportional to the sum of midguts analyzed
in each replicate. *P < 0.05; ***P < 0.0001.
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Materials and Methods
Ethics Statement. All animal procedures were reviewed and approved by the
Imperial College Animal Welfare and Ethical Review Body and carried out in
accordance with the Animal Scientifics Procedures Act 1986 under the United
KingdomHome Office licenses PLL70/7185 and PPL70/8788. Human red blood
cells provided by the National Blood Service of the United Kingdom National
Health Service were obtained from healthy donors upon taking a written
informed consent.
Protein Expression and Purification. Recombinant PfPIMMS43 and PbPIMMS43
were expressed in E. coli (PfPIMMS43 and PbPIMMS43) and S. frugiperda insect
cells (PbPIMMS43). Fragments without the signal peptide and the C-terminal
hydrophobic domain were expressed as Histidine-fusion proteins. Details of
the cloning, expression, and purification are found in SI Appendix, Supple-
mentary Materials and Methods.
Generation of Transgenic Parasites. Two transgenic parasites carrying 50%
and 74% KO of the P. berghei PIMMS43 coding DNA sequence were created
by homologous recombination in the P. berghei c507 and 1804cl1 lines re-
spectively. For the generation of P. berghei transgenic parasites expressing
P. falciparum PIMMS43, the PfPIMMS43 coding sequence was expressed
under the control of the PbPIMMS43 5′UTR and 3′UTR and at the original
PbPIMMS43 locus in the P. berghei c507 line. For the complementation as-
says, we reintroduced the full length PbPIMMS43 in the Δc43 line under the
control of its 5′UTR and 3′UTR and at its original locus. Details of the crea-
tion of these transgenic parasites are found in SI Appendix, Supplementary
Materials and Methods.
RNA-Sequencing. Total RNA was isolated from midguts infected with WT and
PbPIMMS43 KO parasites at 1 and 24 hpbf. The RNA was used to prepare
cDNA libraries (New England Biolabs Ultra prep kit) and run on an Illumina
HiSEq. 3000 instrument. For details, see SI Appendix, Supplementary Mate-
rials and Methods.
Transmission-Blocking Assays. Polyclonal antibodies generated against the
above recombinant proteins were utilized in transmission-blocking assays.
Here, mosquitoes were fed with P. berghei and P. falciparum by SMFAs in the
presence of the generated polyclonal antibodies. Oocyst infection intensity
and oocyst infection prevalence was determined at 10 dpbf. See SI Appen-
dix, Supplementary Materials and Methods.
Other Materials andMethods.Materials andmethods for RT-PCR and qRT-PCR,
Western blot analysis, immunofluorescence assays, phenotypic assays, and
population genetic analysis are described in detail in in SI Appendix, Sup-
plementary Materials and Methods.
Data Availability Statement. The RNA-sequencing data are available through
the European Nucleotide Archive with experiment codes ERX3197375 to
ERX3197410.
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